Rivastigmine Patch 13.3mg 24-Hour Alzheimers & Dementia Symptom Treatment 30/Box

Rivastigmine transdermal patches are used to treat Alzheimer's disease and dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in people with Alzheimer's disease (a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Transdermal rivastigmine is also used to treat dementia in people with Parkinson's disease (a brain system disease with symptoms of slowing of movement, muscle weakness, shuffling walk, and loss of memory). Rivastigmine is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory and thinking) by increasing the amount of a certain natural substance in the brain.

Rivastigmine Transdermal Patch 13.3mg by Mylan Pharmaceuticals is a once-daily medication designed for the management of mild to severe dementia associated with Alzheimer's disease and Parkinson’s disease. Delivering a consistent daily dose of rivastigmine through an easy-to-use, discreet skin patch, this transdermal system offers patients and caregivers a convenient alternative to oral medications, with fewer gastrointestinal side effects and improved compliance.

What It Is Used For

• Indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer’s type.
• Also approved for dementia associated with Parkinson’s disease.
• Offers cognitive, global, and functional benefits by helping slow the progression of symptoms such as memory loss, confusion, and problems with thinking or reasoning.

Details and Features

• Once-daily 24-hour patch: Provides continuous delivery of medication for stable plasma levels and optimal symptom control.
• Strength: 13.3mg/24-hour patch (delivers 13.3mg of rivastigmine over 24 hours).
• Box of 30 patches: One month supply for daily use.
• Reduced GI symptoms: Lower risk of nausea and vomiting vs. oral forms.
• Latex-free, thin, and flexible: Comfortable and discreet for everyday wear.
• User-friendly: Easy to apply, with clear instructions for caregivers and patients.
• Mylan Pharmaceuticals quality: Manufactured under strict quality standards for safety and efficacy.

Dosage

• Recommended Dosage: Apply one 13.3mg patch once daily to clean, dry, hairless skin on the upper or lower back, upper arm, or chest.
• Maximal dose: 13.3mg/24-hour patch is the highest approved dose.
• Dose escalation: If new to therapy, start with a lower-strength patch (4.6mg or 9.5mg/24 hours), only titrating to 13.3mg/24 hours after at least 4 weeks at the prior dose if tolerated.

CDC Guidelines

The CDC refers to the NIH and Alzheimer’s Association guidelines for dementia medication use:

• Rivastigmine patch is an FDA-approved cholinesterase inhibitor for dementia due to Alzheimer’s and Parkinson’s disease.
• Use as part of a comprehensive care plan, including regular assessment of cognitive and functional symptoms, as well as education and support for caregivers.
• Regularly monitor for adverse reactions, proper application technique, and skin tolerance.

Mechanism of Action

Rivastigmine is a cholinesterase inhibitor. It works by inhibiting the breakdown of acetylcholine and butyrylcholine, neurotransmitters essential for memory and cognition. By increasing acetylcholine levels in the brain, rivastigmine helps improve cholinergic function, reducing the symptoms of dementia and enhancing communication between nerve cells.

Directions

1. Choose a clean, dry, hairless skin area. Preferred sites: upper or lower back, upper arm, or chest. Avoid areas with cuts, rashes, or irritation.
2. Remove the old patch before applying a new one (do not use multiple patches at once).
3. Peel off the protective liner and press the patch firmly in place for at least 30 seconds, making sure edges stick well.
4. Rotate application sites to avoid irritation; do not apply to the same spot within 14 days.
5. Wash your hands after applying or removing the patch.
6. Dispose of used patches safely, folded in half with sticky sides together, out of reach of children or pets.
7. Wear patch continuously for 24 hours. Change patch at the same time each day.

Warnings

• Do not use in patients with hypersensitivity to rivastigmine, other carbamate derivatives, or patch components.
• Remove patch before MRI or heat exposure (may cause burns).
• Monitor for skin reactions: If severe rash or irritation develops, discontinue use and consult a healthcare provider.
• May cause stomach/intestinal issues: Use caution in patients with a history of ulcers, GI bleeding, or seizures.
• Bradycardia (slow heartbeat), fainting, or low blood pressure—monitor especially in frail or elderly individuals.
• Not for use in children.
• Avoid simultaneous use with other cholinesterase inhibitors.

Side Effects

Common Side Effects:

• Skin redness, itching, or irritation at application site
• Nausea, vomiting, diarrhea (less common vs. oral forms)
• Loss of appetite, weight loss
• Dizziness, headache, anxiety
• Muscle weakness or tremor

Serious but rare:

• Severe skin reactions or allergic dermatitis
• Gastrointestinal bleeding or ulcers
• Fainting, slow or irregular heartbeat
• Worsening of asthma or other lung disease
• Seizures

If you experience any severe reactions or signs of allergy (rash, swelling, difficulty breathing), remove the patch and seek medical attention immediately.

Rivastigmine Transdermal Patch 13.3mg by Mylan Pharmaceuticals delivers effective, convenient, and reliable 24-hour control of dementia symptoms. Make daily life easier for patients and caregivers with this advanced transdermal solution—trusted for comfort, compliance, and cognitive support.